Anne Rietz
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$3.5MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $3.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 14, 2026 | NIH | SBIR Phase II Novel Therapeutics to Treat HPV-Associated Cancers | $1.1M | Kovina Therapeutics Inc. |
| Apr 1, 2024 | NIH | SBIR Phase II From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer | $1.0M | Kovina Therapeutics Inc. |
| May 1, 2023 | NIH | SBIR Phase II From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer | $910K | Kovina Therapeutics Inc. |
| Mar 1, 2022 | NIH | STTR Phase I From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer | $421K | Kovina Therapeutics Inc. with TRUSTEES OF INDIANA UNIVERSITY |
Peer ranks
Federal funding#497
Awards as PI#566
Patents#273
Companies
- Kovina Therapeutics Inc.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.